雅培股价因婴儿配方奶粉与营养奶昔销售疲软而下跌

投资观察01-22

雅培公司股价周四下挫，这家医疗产品制造商公布令人失望的业绩，其婴儿配方奶粉和营养奶昔业务部门销售低迷是主要原因。

营养业务第四季度销售额同比下降8.9%，该业务包括Similac婴儿配方奶粉和Ensure营养饮品。雅培将下滑归因于销量下降以及为刺激需求采取的降价措施。

公司首席执行官罗伯特·福特在电话会议上向分析师坦言："显然，我们面临挑战。"

营养品销售的下降部分抵消了医疗器械和仿制药业务的增长。

——经调整后每股收益1.50美元，低于FactSet调查分析师预期的1.63美元均值。 ——雅培114.6亿美元的销售额未达到FactSet预期的127.8亿美元。 ——雅培对2026年全年盈利的预测区间涵盖了分析师共识预期，但仍存在不及预期的可能性。

（本文完）

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1188181448?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-22 23:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1188181448","market":"hk","top_or_hot":-1,"title":"雅培股价因婴儿配方奶粉与营养奶昔销售疲软而下跌","media":"投资观察","content":"<p>雅培公司股价周四下挫，这家医疗产品制造商公布令人失望的业绩，其婴儿配方奶粉和营养奶昔业务部门销售低迷是主要原因。</p>\n<p>营养业务第四季度销售额同比下降8.9%，该业务包括Similac婴儿配方奶粉和Ensure营养饮品。雅培将下滑归因于销量下降以及为刺激需求采取的降价措施。</p>\n<p>公司首席执行官罗伯特·福特在电话会议上向分析师坦言：\"显然，我们面临挑战。\"</p>\n<p>营养品销售的下降部分抵消了医疗器械和仿制药业务的增长。</p>\n<p>——经调整后每股收益1.50美元，低于FactSet调查分析师预期的1.63美元均值。\n——雅培114.6亿美元的销售额未达到FactSet预期的127.8亿美元。\n——雅培对2026年全年盈利的预测区间涵盖了分析师共识预期，但仍存在不及预期的可能性。</p>\n<p>（本文完）</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>雅培股价因婴儿配方奶粉与营养奶昔销售疲软而下跌</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n雅培股价因婴儿配方奶粉与营养奶昔销售疲软而下跌\n</h2>\n\n<h4 class=\"meta\">\n\n2026-01-22 23:24 北京时间&nbsp;&nbsp;&nbsp;<strong>投资观察</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>雅培公司股价周四下挫，这家医疗产品制造商公布令人失望的业绩，其婴儿配方奶粉和营养奶昔业务部门销售低迷是主要原因。\n营养业务第四季度销售额同比下降8.9%，该业务包括Similac婴儿配方奶粉和Ensure营养饮品。雅培将下滑归因于销量下降以及为刺激需求采取的降价措施。\n公司首席执行官罗伯特·福特在电话会议上向分析师坦言：\"显然，我们面临挑战。\"\n营养品销售的下降部分抵消了医疗器械和仿制药业务的增长...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE0009355771.USD","symbol_name":"骏利亨德森环球生命科技A Acc","start_time":0,"source_url":"","article_id":"1188181448","we_media_id":"1076224072","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1188181448","pubTimestamp":1769095490,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"投资观察","introduction":"关注海外资本市场一手动态","home_visible":1,"id":"1076224072","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"雅培公司股价周四下挫，这家医疗产品制造商公布令人失望的业绩，其婴儿配方奶粉和营养奶昔业务部门销售低迷是主要原因。营养业务第四季度销售额同比下降8.9%，该业务包括Similac婴儿配方奶粉和Ensure营养饮品。雅培将下滑归因于销量下降以及为刺激需求采取的降价措施。——雅培114.6亿美元的销售额未达到FactSet预期的127.8亿美元。——雅培对2026年全年盈利的预测区间涵盖了分析师共识预期，但仍存在不及预期的可能性。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","BK4566":"资本集团","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","BK4082":"医疗保健设备","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","BK4592":"伊斯兰概念","BK4504":"桥水持仓","SG9999002232.USD":"Allianz Global High Payout USD","LU1914381329.SGD":"Allianz Best Styles Global Equity Cl ET Acc H2-SGD","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","BK4568":"美国抗疫概念","BK4588":"碎股","LU2237957902.USD":"NIKKO AM GLOBAL EQUITY \"F\" (USD) ACC","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","SG9999002224.SGD":"Allianz Global High Payout SGD","LU1989763690.USD":"东方汇理世代食品基金A2 Acc","ABT":"雅培","LU1989763427.SGD":"CPR Invest - Food For Generations A2 Acc SGD-H","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","LU2237957811.SGD":"NIKKO AM GLOBAL EQUITY \"F\" (SGD) ACC","LU2133065610.SGD":"JPMorgan Investment Funds - Global Dividend A (mth) SGD","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","LU2211815571.USD":"ALLIANZ POSITIVE CHANGE \"AT\" (USD) ACC","LU0882574055.USD":"富达全球健康医疗A ACC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU1691799644.USD":"Amundi Funds Polen Capital Global Growth A2 (C) USD","LU1721429741.USD":"BNP PARIBAS SMART FOOD \"CRH\" (USD) INC","LU1721429402.USD":"BNP PARIBAS SMART FOOD \"C\" (USD) ACC","BK4581":"高盛持仓","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","SGXZ41872573.SGD":"ALLIANZ SGD INCOME PLUS \"AM\" (SGD) INC","LU0234572021.USD":"高盛美国核心股票组合Acc","LU0122379950.USD":"贝莱德世界健康科学A2","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","BK4585":"ETF&股票定投概念","LU0058720904.USD":"联博国际健康护理基金A","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC"},"translate_title":"Abbott Stock Drops on Weak Sales of Infant Formula vs. Nutrition Shakes","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABT":1},"content_text":"雅培公司股价周四下挫，这家医疗产品制造商公布令人失望的业绩，其婴儿配方奶粉和营养奶昔业务部门销售低迷是主要原因。\n营养业务第四季度销售额同比下降8.9%，该业务包括Similac婴儿配方奶粉和Ensure营养饮品。雅培将下滑归因于销量下降以及为刺激需求采取的降价措施。\n公司首席执行官罗伯特·福特在电话会议上向分析师坦言：\"显然，我们面临挑战。\"\n营养品销售的下降部分抵消了医疗器械和仿制药业务的增长。\n——经调整后每股收益1.50美元，低于FactSet调查分析师预期的1.63美元均值。\n——雅培114.6亿美元的销售额未达到FactSet预期的127.8亿美元。\n——雅培对2026年全年盈利的预测区间涵盖了分析师共识预期，但仍存在不及预期的可能性。\n（本文完）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1188181448","isCrawlerRequest":true}